Bright Minds Biosciences (DRUG) Earnings Date, Estimates & Call Transcripts $50.94 +6.26 (+14.02%) As of 03:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bright Minds Biosciences Earnings Summary Bright Minds Biosciences issued Q3 2025 earnings on August 14, 2025, reporting an EPS of -$0.53, which beat analysts' consensus estimates of -$0.59 by $0.06. With a trailing EPS of -$0.93, Bright Minds Biosciences' earnings are expected to decrease next year, from ($1.24) to ($3.85) per share. Q3 2025 Earnings ResourcesQ3 2025 Earnings Report Interim ReportPowered by Latest Q3 Earnings DateAug. 14EstimatedConsensus EPS (Aug. 14) -$0.59 Actual EPS (Aug. 14) -$0.53 Beat By $0.06 Get Bright Minds Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bright Minds Biosciences and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataDRUG Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Bright Minds Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ3 20251-$0.76-$0.76-$0.76Q4 20251-$0.89-$0.89-$0.89 2025 2 -$1.65 -$1.65 -$1.65 Q1 20261-$0.98-$0.98-$0.98Q3 20261-$1.58-$1.58-$1.58 Bright Minds Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/14/2025Q3 2025-$0.59-$0.53+$0.06-$0.53--5/15/2025Q2 2025-$0.39-$0.29+$0.10-$0.29--2/13/2025Q1 2025-$0.23$0.01+$0.24$0.01--12/30/2024Q4 2024--$0.12--$0.12--8/14/2024Q3 2024-$0.04-$0.04--5/15/2024Q2 2024--$0.10--$0.10--2/12/2024Q1 2024--$0.32--$0.32--12/29/2023Q4 2023--$0.30--$0.30-- Bright Minds Biosciences Earnings - Frequently Asked Questions When did Bright Minds Biosciences announce their last quarterly earnings? Bright Minds Biosciences (NASDAQ:DRUG) last announced its quarterly earning data on Thursday, August 14, 2025. Learn more on DRUG's earnings history. Did Bright Minds Biosciences beat their earnings estimates last quarter? In the previous quarter, Bright Minds Biosciences (NASDAQ:DRUG) reported ($0.53) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.59) by $0.06. Learn more on analysts' earnings estimate vs. DRUG's actual earnings. How much profit does Bright Minds Biosciences generate each year? Bright Minds Biosciences (NASDAQ:DRUG) has a recorded net income of -$2.06 million. DRUG has generated -$0.93 earnings per share over the last four quarters. What is Bright Minds Biosciences' EPS forecast for next year? Bright Minds Biosciences' earnings are expected to decrease from ($1.24) per share to ($3.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies ZYME Earnings Date STOK Earnings Date UPB Earnings Date SION Earnings Date ORIC Earnings Date PHAR Earnings Date SYRE Earnings Date SPRY Earnings Date PRAX Earnings Date QURE Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Wall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 EarningsWhy Broadcom's Q3 Earnings Were a Huge Win for AVGO BullsAffirm Crushes Earnings Expectations, Turns Bears into BelieversAmbarella's Earnings Prove Its Edge AI Strategy Is a Winner This page (NASDAQ:DRUG) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRUG Stock Alerts